Replies to post #330976 on Bioelectronics Corp (BIEL)

[GetSeriousOK]

The FACT is that RecoveryRx is not approved by the CMS for reimbursement under the NOPAIN Act.

Why not? BIEL's survey studies -- the evidence that you claim qualifies RecoveryRx for the NOPAIN Act -- were published in 2015 and 2019.

The CMS has approved one device, the ON-Q Pump, for reimbursement under the NOPAIN Act. Their clinical study was published in 2015. How did that device get approved?

Phrased a different way: why did the ON-Q Pump get approved while RecoveryRx did not?

Here is a clue: the clinical study for the ON-Q Pump that demonstrates a reduction in opioid use. How is this journal article different from BIEL's survey study journal articles?

https://pubmed.ncbi.nlm.nih.gov/26165259/